CITANEST PLAIN (PRILOCAINE HYDROCHLORIDE) — FDA Approval NDA014763 (ASTRAZENECA)
CITANEST PLAIN (PRILOCAINE HYDROCHLORIDE) — FDA Approval NDA014763 (ASTRAZENECA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CITANEST PLAIN; Active ingredients: PRILOCAINE HYDROCHLORIDE; Application number: NDA014763.
| Brand name | CITANEST PLAIN |
|---|---|
| Active ingredients | PRILOCAINE HYDROCHLORIDE |
| Application number | NDA014763 |
| Sponsor | ASTRAZENECA |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 5 |
| First approval date | 19651118 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →